178 related articles for article (PubMed ID: 17475966)
1. 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases.
Riedl CC; Akhurst T; Larson S; Stanziale SF; Tuorto S; Bhargava A; Hricak H; Klimstra D; Fong Y
J Nucl Med; 2007 May; 48(5):771-5. PubMed ID: 17475966
[TBL] [Abstract][Full Text] [Related]
2. Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study.
Ruers TJ; Wiering B; van der Sijp JR; Roumen RM; de Jong KP; Comans EF; Pruim J; Dekker HM; Krabbe PF; Oyen WJ
J Nucl Med; 2009 Jul; 50(7):1036-41. PubMed ID: 19525451
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Watanabe A; Harimoto N; Yokobori T; Araki K; Kubo N; Igarashi T; Tsukagoshi M; Ishii N; Yamanaka T; Handa T; Oyama T; Higuchi T; Shirabe K
Int J Clin Oncol; 2020 Feb; 25(2):322-329. PubMed ID: 31612350
[TBL] [Abstract][Full Text] [Related]
4. A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.
Tan MC; Castaldo ET; Gao F; Chari RS; Linehan DC; Wright JK; Hawkins WG; Siegel BA; Delbeke D; Pinson CW; Strasberg SM
J Am Coll Surg; 2008 May; 206(5):857-68; discussion 868-9. PubMed ID: 18471711
[TBL] [Abstract][Full Text] [Related]
5. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
6. Fluorine-18-fluorodeoxyglucose uptake of bone marrow on PET/CT can predict prognosis in patients with colorectal cancer after curative surgical resection.
Lee JW; Baek MJ; Ahn TS; Lee SM
Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):187-194. PubMed ID: 29120905
[TBL] [Abstract][Full Text] [Related]
7. Validation of several SUV-based parameters derived from 18F-FDG PET for prediction of survival after SIRT of hepatic metastases from colorectal cancer.
Fendler WP; Philippe Tiega DB; Ilhan H; Paprottka PM; Heinemann V; Jakobs TF; Bartenstein P; Hacker M; Haug AR
J Nucl Med; 2013 Aug; 54(8):1202-8. PubMed ID: 23729697
[TBL] [Abstract][Full Text] [Related]
8. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery.
Kalff V; Duong C; Drummond EG; Matthews JP; Hicks RJ
J Nucl Med; 2006 Jan; 47(1):14-22. PubMed ID: 16391182
[TBL] [Abstract][Full Text] [Related]
9. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).
Fernandez FG; Drebin JA; Linehan DC; Dehdashti F; Siegel BA; Strasberg SM
Ann Surg; 2004 Sep; 240(3):438-47; discussion 447-50. PubMed ID: 15319715
[TBL] [Abstract][Full Text] [Related]
10. Role of FDG-PET staging in selecting the optimum patient for hepatic resection of metastatic colorectal cancer.
Strasberg SM; Dehdashti F
J Surg Oncol; 2010 Dec; 102(8):955-9. PubMed ID: 21165998
[TBL] [Abstract][Full Text] [Related]
11. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study.
Strasberg SM; Dehdashti F; Siegel BA; Drebin JA; Linehan D
Ann Surg; 2001 Mar; 233(3):293-9. PubMed ID: 11224615
[TBL] [Abstract][Full Text] [Related]
12. Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET.
Wong CY; Salem R; Qing F; Wong KT; Barker D; Gates V; Lewandowski R; Hill EA; Dworkin HJ; Nagle C
J Nucl Med; 2004 Nov; 45(11):1892-7. PubMed ID: 15534060
[TBL] [Abstract][Full Text] [Related]
13. Preoperative FDG-PET-scan in patients with resectable colorectal liver metastases does not improve overall survival: a retrospective analyses stratified by clinical risk score.
Ayez N; de Ridder J; Wiering B; Oyen WJ; de Wilt JH; Verhoef C
Dig Surg; 2013; 30(4-6):451-8. PubMed ID: 24458160
[TBL] [Abstract][Full Text] [Related]
14. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of
Shim JR; Lee SD; Han SS; Lee SJ; Lee DE; Kim SK; Kim SH; Park SJ; Oh JH
Eur J Surg Oncol; 2018 May; 44(5):670-676. PubMed ID: 29459018
[TBL] [Abstract][Full Text] [Related]
16. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
17. A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
Watanabe A; Harimoto N; Araki K; Yoshizumi T; Arima K; Yamashita Y; Baba H; Tetsuya H; Kuwano H; Shirabe K
J Surg Oncol; 2018 Dec; 118(7):1088-1095. PubMed ID: 30261101
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.
Park JW; Kim JH; Kim SK; Kang KW; Park KW; Choi JI; Lee WJ; Kim CM; Nam BH
J Nucl Med; 2008 Dec; 49(12):1912-21. PubMed ID: 18997056
[TBL] [Abstract][Full Text] [Related]
19. Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Kondo H; Nakajima T; Yamamoto N
Lung Cancer; 2011 Feb; 71(2):144-50. PubMed ID: 20646779
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography in predicting survival in patients with unresectable metastatic melanoma to the liver undergoing yttrium-90 radioembolization.
Piduru SM; Schuster DM; Barron BJ; Dhanasekaran R; Lawson DH; Kim HS
J Vasc Interv Radiol; 2012 Jul; 23(7):943-8. PubMed ID: 22609292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
